首页|银杏达莫与奥扎格雷联合治疗脑梗死的效果研究

银杏达莫与奥扎格雷联合治疗脑梗死的效果研究

扫码查看
目的 观察银杏达莫与奥扎格雷联合治疗脑梗死的临床疗效,为制订临床药物治疗方案提供参考,改善脑梗死患者的预后.方法 选取2018年1月-2022年10月聊城市茌平区人民医院收治的脑梗死患者200例开展研究,采用随机数字表法分为对照组和观察组各100例.对照组实施奥扎格雷治疗,观察组在对照组的基础上联合银杏达莫治疗.比较两组临床治疗总有效率.结果 观察组治疗总有效率为99.00%,明显高于对照组的92.00%,差异有统计学意义(x2=5.701,P<0.05).结论 脑梗死患者主要采取药物治疗,奥扎格雷属于选择性血栓素合成酶抑制剂,银杏达莫存在多种有效成分,和单一用药相比,二者联合用药治疗能有效改善神经功能,提升患者治疗效果,值得临床推广应用.
Study on the effect of the combination of ginkgo biloba extract and ozagrel in the treatment of cerebral infarction
Objective To observe the clinical efficacy of the combination of ginkgo biloba extract and ozagrel in the treatment of cerebral infarction,in order to provide reference for the formulation of clinical drug treatment plans,and improve the prognosis of patients with cerebral infarction.Methods A study was conducted on 200 patients with cerebral infarction admitted to Liaocheng Chiping District People's Hospital from January 2018 to October 2022.They were divided into control group and observation group,with 100 cases in each group,using random number table method.The control group received treatment with ozagrel,while the observation group received treatment with the combination of ginkgo biloba extract on the basis of the control group.The total effective rate of clinical treatment between two groups was compared.Results The total effective rate of the observation group was 99.00%,which was significantly higher than the 92.00%of the control group,and the difference was statistically significant(x2=5.701,P<0.05).Conclusion Drug therapy was mainly used for patients with cerebral infarction.Ozagrel belonged to the category of selective thromboxane synthase inhibitors,and ginkgo biloba extract contained multiple active ingredients.Compared with single drug therapy,the combination of the two could effectively improve neurological function and enhance patient treatment efficacy,which was worthy of clinical promotion and application.

Ginkgo biloba extractOzagrelCerebral infarction

王晓青、姜超

展开 >

聊城市茌平区人民医院神经内科,山东 聊城 252100

银杏达莫 奥扎格雷 脑梗死

2024

中国城乡企业卫生
中华预防医学会 天津市职业病防治院

中国城乡企业卫生

影响因子:0.239
ISSN:1003-5052
年,卷(期):2024.39(3)
  • 10